SARAH CRANDALL-FLETCHER: Open Payments
NPI 1588672075 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 40 payments from 15 companies in 2025. Trend: 2023 $2,642 · 2024 $1,814 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 7 | $117 |
| Janssen Biotech, Inc. | 4 | $89 |
| Celltrion USA Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $79 |
| Madrigal Pharmaceuticals | 4 | $78 |
| GENZYME CORPORATION | 3 | $73 |
| Novo Nordisk Inc | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| PFIZER INC. | 2 | $34 |
| Lundbeck LLC | 2 | $30 |
Products named: DUPIXENT, IBSRELA, TREMFYA, VEGZELMA, REZDIFFRA, Wegovy, RINVOQ, VELSIPITY.
Industry payments across WV — which companies pay providers there.
